Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Serenace
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Serenace 500microgram capsules
0402010J0BEAAAA
|
Serenace | Haloperidol | Central Nervous System | 5 |
|
Serenace 1.5mg tablets
0402010J0BEABAJ
|
Serenace | Haloperidol | Central Nervous System | No data available |
|
Serenace 10mg tablets
0402010J0BEADAL
|
Serenace | Haloperidol | Central Nervous System | No data available |
|
Serenace 20mg tablets
0402010J0BEAEAM
|
Serenace | Haloperidol | Central Nervous System | No data available |
|
Serenace 20mg/2ml solution for injection ampoules
0402010J0BEAHAD
|
Serenace | Haloperidol | Central Nervous System | No data available |
|
Serenace 2mg/ml liquid
0402010J0BEAFAG
|
Serenace | Haloperidol | Central Nervous System | No data available |
|
Serenace 5mg tablets
0402010J0BEACAK
|
Serenace | Haloperidol | Central Nervous System | No data available |
|
Serenace 5mg/1ml solution for injection ampoules
0402010J0BEAGAC
|
Serenace | Haloperidol | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.